Navigation Links
Capitol chemistry: How Congress will alter the science landscape in 2014
Date:1/29/2014

The Congressional agenda for 2014 includes science issues with far-reaching implications for an array of issues including public health, job growth, pharmaceutical research and energy, according to an article in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society. The mid-term elections occurring this fall, however, promise to complicate progress on key legislative efforts, already stymied by a bitter partisan atmosphere.

Among the topics that the article addresses is the modernization of the Toxic Substances Control Act, a law that governs commercial chemicals. In a rare bipartisan effort, policymakers from both sides of the aisle are helping refine legislation, which was introduced last year. As it gains bipartisan momentum, private sector interests are adding friction and could affect the strength of specific provisions. Other article highlights include forecasts for energy bills to address power plant emissions and nuclear waste disposal; science policy that could encourage research and development or make it more difficult; and consumer protection laws affecting dietary supplements and antibiotics.

In addition to bills with the most obvious ties to chemical research and businesses, the article notes that industry experts also must keep a keen eye on intertwined agricultural and international issues as well. For example, the farm bill could include provisions that affect pesticide use, and trade agreements have the potential to boost domestic job growth in the chemical industries.


'/>"/>
Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related biology news :

1. Stanford expert brings climate change science to heated Capitol Hill
2. Biochemistry: Unspooling DNA from nucleosomal disks
3. 7th World Congress for Rett Syndrome to convene in New Orleans, La., June 22-26
4. Purdue professor to speak before Congress about nanotechnology in brain treatment research
5. ESMO 2012 Congress: A path for medical oncology innovations
6. MARC Travel Awards announced for 2012 XXXI Congress of the Societa Italiana di Pathologia e Medicina
7. International congress on behavior, animal husbandry and animal well-being in Vienna
8. 2016 International Congress of Entomology to be held in Orlando, Florida
9. Madidi conservationist wins award at World Conservation Congress
10. Noteworthy studies at the ESMO 2012 Congress
11. Majority of Americans doubt Congress and White House can avoid fiscal cliff
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2016)... 21, 2016   Neurotechnology , a provider ... today announced that the MegaMatcher On Card fingerprint ... for the NIST Minutiae Interoperability Exchange (MINEX) ... mandatory steps of the evaluation protocol. ... test of fingerprint templates used to establish compliance ...
(Date:11/17/2016)... 17, 2016 Global Market Watch: Primarily ... Banks, Population-Based Banks and Academics) market is to witness a ... Biobanks shows the highest Compounded Annual Growth Rate (CAGR) of ... during the analysis period 2014-2020. North America ... followed by Europe at 9.56% respectively. ...
(Date:11/16/2016)... SANTA CLARA, Calif. , Nov. 16, 2016 /PRNewswire/ ... company enhancing user experience and security for consumer ... provider for the financial and retail industry, today ... more secure and convenient way to authenticate users ... now uses Sensory,s TrulySecure™ software which ...
Breaking Biology News(10 mins):
(Date:12/6/2016)... DIEGO , Dec. 6, 2016  Creative Medical ... Kesari , MD, PhD, FANA, FAAN to the Company,s ... neurology and clinical trials to assist the Company,s clinical ... stroke. The AmnioStem product is a universal donor stem cell ... activity in animal models of stroke 1 .  ...
(Date:12/6/2016)... ... December 06, 2016 , ... ProMIS ... of precision treatments for neurodegenerative diseases, today announced the validated monoclonal antibody ... direct neurotoxic effect of prion-like forms of Amyloid beta (Aß) in vitro. ...
(Date:12/5/2016)... 5, 2016 Research and Markets has ... Technologies, Markets and Companies" to their offering. ... , , ... using various -omics technologies such as proteomics and metabolomics. Molecular diagnostics ... are also based on biomarker. Currently the most important ...
(Date:12/5/2016)... 2016  Renova™ Therapeutics, a biotechnology company developing ... other chronic diseases, announced that Catherine Bovenizer ... Financial Officer (CFO), effective today. Ms. ... experience in financial management for a variety of ... Most recently, Ms. Bovenizer was the Vice President ...
Breaking Biology Technology: